ZOGENIX INTERNATIONAL LIMITED

08330213
Active Windlesham

Other professional, scientific and technical activities n.e.c.

0 employees website.com
Other professional, scientific and technical activities n.e.c.
Z

ZOGENIX INTERNATIONAL LIMITED

08330213

Other professional, scientific and technical activities n.e.c.

Founded 13 Dec 2012 Active Windlesham, England 0 employees website.com
Other professional, scientific and technical activities n.e.c.

Previous Company Names

BRABANT PHARMA LIMITED 13 Dec 2012 — 17 Nov 2015
Accounts Submitted 25 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 28 May 2026 Next due 11 Jun 2027 11 months remaining
Net assets £-302M £18M 2024 year on year
Total assets £44M £23M 2024 year on year
Total Liabilities £346M £5M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Windlesham Campus Sunninghill Road Windlesham Surrey GU20 6PP England

Full company profile for ZOGENIX INTERNATIONAL LIMITED (08330213), an active company based in Windlesham, England. Incorporated 13 Dec 2012. Other professional, scientific and technical activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2014–2024)

Cash in Bank

N/A

Net Assets

-£301.84M

Decreased by £18.11M (-6%)

Total Liabilities

£346.21M

Decreased by £4.74M (-1%)

Turnover

£56.08M

Decreased by £45.19M (-45%)

Employees

N/A

Debt Ratio

780%

Increased by 258 (+49%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

8 Allotments 160,188 Shares £6.89m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
24 Oct 2014126,275£5.46m£43.239
24 Apr 201412,778£575k£45
24 Apr 201446£2k£45
20 Dec 20134,439£200k£45
8 Mar 201338£2k£40

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Zogenix Europe Limited
100.0%

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Zogenix Europe Limited

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent

Ucb Biosciences Inc.

Unknown

Active
Notified 12 Jan 2026
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Group Structure

Group Structure

ZOGENIX EUROPE LIMITED united kingdom
ZOGENIX INTERNATIONAL LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
The Pearce Building, West Street, Maidenhead (SL6 1RL) WINDSOR AND MAIDENHEAD
Leasehold-25 Feb 2020
The Pearce Building, West Street, Maidenhead (SL6 1RL)
Leasehold
Added 25 Feb 2020
District WINDSOR AND MAIDENHEAD

Documents

Company Filings

DateCategoryDescriptionDocument
28 May 2026Confirmation StatementConfirmation statement made on 28 May 2026 with no updates
13 Jan 2026Persons With Significant ControlCessation of Zogenix Europe Limited as a person with significant control on 12 Jan 2026
13 Jan 2026Persons With Significant ControlUcb Biosciences Inc. notified as a person with significant control
25 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
21 May 2025Confirmation StatementConfirmation statement made on 15 May 2025 with no updates
28 May 2026 Confirmation Statement

Confirmation statement made on 28 May 2026 with no updates

13 Jan 2026 Persons With Significant Control

Cessation of Zogenix Europe Limited as a person with significant control on 12 Jan 2026

13 Jan 2026 Persons With Significant Control

Ucb Biosciences Inc. notified as a person with significant control

25 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

21 May 2025 Confirmation Statement

Confirmation statement made on 15 May 2025 with no updates

Recent Activity

Latest Activity

Confirmation statement made on 28 May 2026 with no updates

3 weeks ago on 28 May 2026

Cessation of Zogenix Europe Limited as a person with significant control on 12 Jan 2026

5 months ago on 13 Jan 2026

Ucb Biosciences Inc. notified as a person with significant control

5 months ago on 13 Jan 2026

Annual accounts made up to 31 Dec 2024

9 months ago on 25 Sept 2025

Confirmation statement made on 15 May 2025 with no updates

1 years ago on 21 May 2025